Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Sleep Apnea - Pipeline Review, H2 2016 - Research and Markets

Research and Markets
Posted on: 20 Sep 16

Research and Markets has announced the addition of the "Sleep Apnea - Pipeline Review, H2 2016" report to their offering.

The report provides comprehensive information on the therapeutics under development for Sleep Apnea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sleep Apnea and features dormant and discontinued projects.

According to 'Sleep Apnea - Pipeline Review, H2 2016'; Sleep Apnea pipeline therapeutics constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by Companies and remaining by the Universities Institutes.

Furthermore, the publisher says: Sleep Apnea is a potentially serious sleep disorder in which breathing repeatedly stops and starts. Symptoms include hypersomnia, morning headache, insomnia, dry mouth or sore throat when wake up. Risk factors include excess weight, family history, smoking and narrowed airway.

It also reviews of key players involved in therapeutic development for Sleep Apnea and features dormant and discontinued projects. Currently, The molecules developed by Companies in Phase III, Phase II and Preclinical stages are 1, 3 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Key Topics Covered:

  1. Introduction
  2. Sleep Apnea Overview
  3. Therapeutics Development
  4. Pipeline Products for Sleep Apnea - Overview
  5. Pipeline Products for Sleep Apnea - Comparative Analysis
  6. Sleep Apnea - Therapeutics under Development by Companies
  7. Sleep Apnea - Therapeutics under Investigation by Universities/Institutes
  8. Sleep Apnea Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Sleep Apnea - Products under Development by Companies
  13. Sleep Apnea - Products under Investigation by Universities/Institutes
  14. Sleep Apnea - Companies Involved in Therapeutics Development
  • Galleon Pharmaceuticals
  • RespireRx Pharmaceuticals Inc.
  • SK Biopharmaceuticals Co., Ltd.
  • Vivus, Inc.

For more information about this report visit

Related Topics: Respiratory Drugs

View source version on

Business Wire

Last updated on: 20/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.